Sentence examples for levodopa compared to from inspiring English sources

Furthermore, our patients who developed dyskinesias started on average of 0.6 years earlier with levodopa compared to the PDNDYS group (3.0 and 2.4 years, respectively) due to the longer disease duration, hence the difference in duration of levodopa use.

In Session 2, participants performed stimulus-specific selections to abstract images they had previously learned in Session 1. Participants treated with levodopa compared to those on placebo demonstrated unambiguously less efficient acquisition of stimulus-response associations.

In the current study the LID group received a significantly higher dose of levodopa compared to the No-LID group.

45 Different studies have been published looking at the cost-effectiveness of pramipexole with no levodopa therapy, compared to levodopa monotherapy and to rasagiline in early PD.

Tolcapone was associated with significantly greater reduction of levodopa dose compared to entacapone (p = 0.05) and was also superior with respect to 'wearing off ' severity and relevant clinical improvement (70%73%% for tolcapone vs 56% for entacapone).

Average STN-GP phase difference LFP beta amplitude profiles obtained from OFF levodopa recordings were compared to those obtained following levodopa challenge using repeated measures ANOVA.

The study was designed to test the efficacy and safety of rasagiline as an adjunct to levodopa compared with placebo and to compare effects of entacapone with placebo.

Novel word learning was significantly enhanced in both the d-amphetamine and levodopa groups as compared to the placebo group.

A dopamine derivative N-3,4-bis(pivaloyloxy -dopamine (Bpivaloyloxy -dopamineped in our group has demonstrated superior therapeutic outcome compared to levodopa in a PD mice model.

Two trials (CALM-PD-CIT and REAL-PET studies) used neuroimaging dopamine changes as a surrogate marker for PD progression, and concluded that pramipexole and ropinirole could have a neuroprotective effect compared to levodopa.

Using US preference weights rather than UK preference weights reduced the probability that pramipexole was cost-effective compared to levodopa.